ewIMID Program - 28-30 Nov

Download the Final Program here.

Access the abstracts of ewIMID'12 here. 

 

Wednesday, 28 November 2012

13.00   
Registration
 

 

 

Session 1: Fibrosis
Chairs: Tim Radstake and Gijs van den Brink
 
14.00               

Keynote 1: Fibrosis and cancer

Raghu Kalluri, Boston, USA

 

 

Selected Oral Presentations

14.45 NF-kappaB inducing kinase (NIK) is a key regulator of inflammation-induced angiogenesis
Ae-Ri Noort, Katinka P.M. van Zoest, Pieter Koolwijk, Paul-Peter Tak, Sander W. Tas (The Netherlands)
15.00
Graft versus host disease in humanized mice is differentially controlled by CD28 and CD80/86 antagonists

Nicolas Poirier, Nahzli Dilek, Caroline Mary, Bernard Vanhove (France) 

15.15
 

Analysis of dendritic cells in human lymphoid organs
Gordon F. Heidkamp, Nathalie Eissing, Lukas Heger, Robert Cesnjevar, Arndt Hartmann, Johannes Zenk, Evelyn Ulrich, Andreas Mackensen, Gerold Schuler, Burkhard Schauf, Falk Nimmerjahn, Diana Dudziak (Germany)

 

15.30
 

 

Coffee Break and Poster Viewing

 

  Session 2: Gene Therapy in Eye Disease
Chairs: Martin van Hagen and Tim Radstake
 
16.15

Immunology and possible new therapies for age related macular degeneration

Robert Nussenblatt, Bethesda, USA

16.45 

Lighting a candle in the dark: Advances in the genetics and (gene) therapy of retinal dystrophies

Anneke den Hollander, Nijmegen, The Netherlands
 

 

 

Special Lecture supported by Janssen Biologics

17.15  

Targeting immunoregulatory pathways in RA

Michael Ehrenstein, London, UK

 

18.00
 
Welcome Reception
 


Thursday, 29 November 2012

 

Session 3: Functional Genomics
Chairs: Hermann Eibel – Thomas Giese
     
08.30       

Genetic variation at the human Fc gamma receptor locus as the major receptors for IgG

Taco Kuijper, Amsterdam, The Netherlands

09.00

Patient stratification and genomics: Flares, fizzlers and foxes

Ken Smith, Cambridge, UK

09.30

Finding new immune regulatory genes by ENU mutagenesis

Anselm Enders, Canberra, Australia

 

10.00
 

Poster Tour 1 and Coffee Break in the Exhibition Area
 
  Session 4: Challenges in Human Immunology
Chairs: Leonie Taams and Florence Apparailly
 
11.00

Type 1 regulatory T cells: From the bench to the bedside

Silvia Gregori, Milan, Italy

11.30
What does it take to be healthy? Investigating immune-deficiency in non-immunodeficient scenarios
Adrian Hayday, London, UK
 
12.30
 
Lunch
 
14.00
 

Satellite Symposium organized by Abbott

Cross-disciplinary considerations in treatment of IMIDs

Chair: Martin van Hagen

 

 
Success and failure of drugs for IBD, what can we learn for other IMIDs?
Gijs R. van den Brink, Amsterdam, The Netherlands
 
Role of adipocytokines in IMIDs and associated cardiovascular disease
Michael T. Nurmohamed, Amsterdam, The Netherlands
 
Non-infectious uveitis, a common IMID-related comorbidity: Pathophysiology and management
Bahram Bodaghi, Paris, France

 

15.30
 

 

Coffee Break and Poster Viewing
 


 
Session 5: Environmental Factors
Chairs: Jagadeesh Bayry and Ola Winqvist
 
16.30

Intestinal immunity marches on its stomach

Marc Veldhoen, Cambridge, UK

17.00

Follicular lymphomagenesis: Early steps and associated risk factors

Sandrine Roulland, Marseille, France

 

 

Session 6: Diabetes and Metabolism
Chairs: Joao Fonseca & Falk Nimmerjahn
 
17.30

 Islet autoimmunity initiates in infancy: Evidence from type 1 diabetes natural history studies

 Anette Ziegler, Munich, Germany

18.00

Type 1 diabetes - An autoinflammatory disease: A new concept, new therapeutical strategies

Catarina Limbert, Lisbon, Portugal

 

19.30
 
Workshop Dinner – Guest speaker: Mike Stroud, UK
 

 

Friday, 30 November 2012

 

09.00

Satellite Symposium organized by Pfizer

Cytokines and kinase pathways in immune-mediated inflammatory diseases: Current thoughts and future perspectives

 Chair: Ernest Choy

 
Welcome
Ernest Choy, Cardiff, UK
 
Examining cytokine signalling pathways in immune-mediated inflammatory diseases
Ernest Choy, Cardiff, UK
 
The role of cytokine signalling in inflammatory skin diseases
Frank Nestle, London, UK
  Dysregulation and the complexity of signalling in fibrosis
Jörg Distler, Erlangen Germany
 
Emerging cytokine signalling pathways: Future perspectives
Thomas Decker, Vienna, Austria
 
Discussion and Close
Ernest Choy, Cardiff, UK
   
10.30
 
Poster Tour 2 and Coffee Break in the Exhibition Area
 

 

Session 7: Novelties In Multiple Sclerosis - Time for a Change?
Chairs: Bing Thio and Christian Jorgensen
 
11.30

 

Effects of dimethyl fumarate, a new treatment option in multiple
sclerosis, on neuroprotection and immunomodulation.
Axel Methner, Mainz, Germany
 
12.00

Treg in CNS autoimmune disease

Stephen M. Anderton, Edinburgh, UK

 

 

Selected oral presentations 
 

12.30
No lack of regulatory B cells in patients with Multiple Sclerosis
Laure Michel, Mélanie Chesneau, Philippe Manceau, Alexandra Garcia, Marion Salou, Annie Elong Ngono, Annaïck Pallier, Marylène Jacq-Foucher, Fabienne Lefrère, Sandrine Wiertlewski, Jean-Paul Soulillou, Nicolas Degauque, David-Axel Laplaud, Sophie Brouard (France) 
12.45

The role of Bob1 in rheumatoid arthritis: Potential implications for autoimmunity

Nataliya Yeremenko, Tineke Cantaert, Melissa N. van Tok, Ioana Gofita, Juan D. Canete, Paul-Peter Tak, Hergen Spits, Dominique L. Baeten (The Netherlands & Spain)

13.00
Role of Ras isoforms in gd T-cell development
Ana V. Marín-Marín, Eva Jiménez Pérez, Eugenio Santos, Edgar Fernández-Malavé (Spain)

 

13.15
 

 

Lunch
 

  Session 8: Innate Lymphoid Cells
Chairs: Lars Rogge and Regis Josien

     
14.15

Keynote 3: IL-23 driven autoimmunity goes innate

Burkhard Becher, Zurich, Switzerland

15.00

Keynote 4: The role of Innate Lymphoid Cells in inflammatory diseases

Hergen Spits, Amsterdam, The Netherlands

 

15.45
 
Closing remarks